Intralesional treatment with meglumine antimoniate in three patients with New World cutaneous leishmaniasis and large periarticular lesions with comorbidities

Intralesional treatment with meglumine antimoniate in three patients with New World cutaneous leishmaniasis and large periarticular lesions with comorbidities

Abstract Although New World cutaneous leishmaniasis is not itself a life-threatening disease, its treatment with systemic antimonials can cause toxicity that can be dangerous to some patients. Intralesional meglumine antimoniate provides a viable, less toxic alternative. Herein, we describe an alter...

Full description

Bibliographic Details
Main Authors: Maria Inês Fernandes Pimentel, Érica de Camargo Ferreira e Vasconcellos, Carla de Oliveira Ribeiro, Marcelo Rosandiski Lyra, Mauricio Naoto Saheki, Mariza de Matos Salgueiro, Liliane de Fátima Antonio, Armando de Oliveira Schubach
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT)
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Cutaneous leishmaniasis
Meglumine antimoniate
Intralesional injections
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822017000200269&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822017000200269&lng=en&tlng=en

Similar Items